ranibizumab [Ranibizumab] tematický

Termíny

Lucentis

 

Lucentis
RhuFab V2

Perzistentní odkaz   https://www.medvik.cz/link/D000069579
Definice

A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.

DUI
D000069579
CUI
M0481787
RN
ZL1R02VT79
Historická pozn.
2016 (2005)
Veřejná pozn.
2016; RANIBIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011

Povolená podhesla

AN
analýza 0
AD
aplikace a dávkování 15
BI
biosyntéza 0
CH
chemie 0
HI
dějiny 0
EC
ekonomika 0
PK
farmakokinetika 3
PD
farmakologie 15
PH
fyziologie 0
GE
genetika 0
IM
imunologie 0
IP
izolace a purifikace 0
CL
klasifikace 0
BL
krev 0
ME
metabolismus 0
UR
moč 0
CF
mozkomíšní mok 0
PO
otrava 0
AE
škodlivé účinky 3
TU
terapeutické užití 36
TO
toxicita 0
DE
účinky léků 0
RE
účinky záření 0
UL
ultrastruktura 0

D Chemikálie a léčiva
D12 aminokyseliny, peptidy a proteiny
D12.776 proteiny
D12.776.124 krevní proteiny
D12.776.124.486 imunoproteiny
D12.776.124.486.485 imunoglobuliny
D12.776.124.486.485.114 protilátky
D12.776.124.486.485.114.224 monoklonální protilátky
D12.776.124.486.485.114.224.060 humanizované monoklonální protilátky
D12.776.124.486.485.114.224.060.125 abciximab
D12.776.124.486.485.114.224.060.250 adalimumab
D12.776.124.486.485.114.224.060.313 alemtuzumab
D12.776.124.486.485.114.224.060.344 basiliximab
D12.776.124.486.485.114.224.060.375 bevacizumab
D12.776.124.486.485.114.224.060.438 brentuximab vedotin
D12.776.124.486.485.114.224.060.500 certolizumab pegol
D12.776.124.486.485.114.224.060.750 cetuximab
D12.776.124.486.485.114.224.060.766 daklizumab
D12.776.124.486.485.114.224.060.782 denosumab
D12.776.124.486.485.114.224.060.790 gemtuzumab
D12.776.124.486.485.114.224.060.794 inotuzumab ozogamicin
D12.776.124.486.485.114.224.060.798 ipilimumab
D12.776.124.486.485.114.224.060.813 natalizumab
D12.776.124.486.485.114.224.060.829 nivolumab
D12.776.124.486.485.114.224.060.844 omalizumab
D12.776.124.486.485.114.224.060.860 palivizumab
D12.776.124.486.485.114.224.060.864 panitumumab
D12.776.124.486.485.114.224.060.866 ramucirumab
D12.776.124.486.485.114.224.060.868 ranibizumab
D12.776.124.486.485.114.224.060.875 trastuzumab
D12.776.124.486.485.114.224.060.937 ustekinumab
D12.776.124.790 sérové globuliny
D12.776.124.790.651 imunoglobuliny
D12.776.124.790.651.114 protilátky
D12.776.124.790.651.114.224 monoklonální protilátky
D12.776.124.790.651.114.224.060 humanizované monoklonální protilátky
D12.776.124.790.651.114.224.060.125 abciximab
D12.776.124.790.651.114.224.060.250 adalimumab
D12.776.124.790.651.114.224.060.375 alemtuzumab
D12.776.124.790.651.114.224.060.407 basiliximab
D12.776.124.790.651.114.224.060.438 bevacizumab
D12.776.124.790.651.114.224.060.469 brentuximab vedotin
D12.776.124.790.651.114.224.060.500 certolizumab pegol
D12.776.124.790.651.114.224.060.750 cetuximab
D12.776.124.790.651.114.224.060.766 daklizumab
D12.776.124.790.651.114.224.060.782 denosumab
D12.776.124.790.651.114.224.060.790 gemtuzumab
D12.776.124.790.651.114.224.060.794 inotuzumab ozogamicin
D12.776.124.790.651.114.224.060.798 ipilimumab
D12.776.124.790.651.114.224.060.813 natalizumab
D12.776.124.790.651.114.224.060.829 nivolumab
D12.776.124.790.651.114.224.060.844 omalizumab
D12.776.124.790.651.114.224.060.860 palivizumab
D12.776.124.790.651.114.224.060.864 panitumumab
D12.776.124.790.651.114.224.060.866 ramucirumab
D12.776.124.790.651.114.224.060.868 ranibizumab
D12.776.124.790.651.114.224.060.875 trastuzumab
D12.776.124.790.651.114.224.060.937 ustekinumab
D12.776.377 globuliny
D12.776.377.715 sérové globuliny
D12.776.377.715.548 imunoglobuliny
D12.776.377.715.548.114 protilátky
D12.776.377.715.548.114.224 monoklonální protilátky
D12.776.377.715.548.114.224.200 humanizované monoklonální protilátky
D12.776.377.715.548.114.224.200.125 abciximab
D12.776.377.715.548.114.224.200.250 adalimumab
D12.776.377.715.548.114.224.200.375 alemtuzumab
D12.776.377.715.548.114.224.200.407 basiliximab
D12.776.377.715.548.114.224.200.438 bevacizumab
D12.776.377.715.548.114.224.200.469 brentuximab vedotin
D12.776.377.715.548.114.224.200.500 certolizumab pegol
D12.776.377.715.548.114.224.200.750 cetuximab
D12.776.377.715.548.114.224.200.766 daklizumab
D12.776.377.715.548.114.224.200.782 denosumab
D12.776.377.715.548.114.224.200.790 gemtuzumab
D12.776.377.715.548.114.224.200.794 inotuzumab ozogamicin
D12.776.377.715.548.114.224.200.798 ipilimumab
D12.776.377.715.548.114.224.200.813 natalizumab
D12.776.377.715.548.114.224.200.829 nivolumab
D12.776.377.715.548.114.224.200.844 omalizumab
D12.776.377.715.548.114.224.200.860 palivizumab
D12.776.377.715.548.114.224.200.864 panitumumab
D12.776.377.715.548.114.224.200.866 ramucirumab
D12.776.377.715.548.114.224.200.868 ranibizumab
D12.776.377.715.548.114.224.200.875 trastuzumab
D12.776.377.715.548.114.224.200.937 ustekinumab

Přidat